| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.
|
J Virol
|
2001
|
3.05
|
|
2
|
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients.
|
J Clin Microbiol
|
2001
|
2.45
|
|
3
|
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.
|
Antimicrob Agents Chemother
|
1999
|
2.08
|
|
4
|
Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting.
|
AIDS
|
1999
|
1.85
|
|
5
|
High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire.
|
J Acquir Immune Defic Syndr
|
2001
|
1.71
|
|
6
|
Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel.
|
AIDS
|
2000
|
1.53
|
|
7
|
Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples.
|
AIDS
|
2000
|
1.43
|
|
8
|
[Virological evaluation of treating HIV-infected patients with (combinations of) antiretroviral drugs at the Amsterdam Academic Medical Center, 1996/'97].
|
Ned Tijdschr Geneeskd
|
1998
|
1.39
|
|
9
|
Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure.
|
J Infect Dis
|
1998
|
1.26
|
|
10
|
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters.
|
Proc Natl Acad Sci U S A
|
2001
|
1.26
|
|
11
|
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure.
|
AIDS
|
2000
|
1.23
|
|
12
|
Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants.
|
J Virol
|
2001
|
1.20
|
|
13
|
Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples.
|
Nucleosides Nucleotides Nucleic Acids
|
2001
|
1.19
|
|
14
|
Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART.
|
Virus Genes
|
2001
|
1.16
|
|
15
|
Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up.
|
Antivir Ther
|
2001
|
1.14
|
|
16
|
Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride.
|
Antimicrob Agents Chemother
|
1998
|
1.12
|
|
17
|
The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
|
AIDS
|
1998
|
1.11
|
|
18
|
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen.
|
AIDS
|
2000
|
1.10
|
|
19
|
Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
|
Virology
|
2000
|
1.03
|
|
20
|
HIV drug susceptibility and treatment response to mega-HAART regimen in patients from the Frankfurt HIV cohort.
|
Antivir Ther
|
2000
|
1.01
|
|
21
|
The impact of individual human immunodeficiency virus type 1 protease mutations on drug susceptibility is highly influenced by complex interactions with the background protease sequence.
|
J Virol
|
2009
|
0.98
|
|
22
|
Lateral bead-chain urethrocystography after successful and unsuccessful colposuspension.
|
Br J Obstet Gynaecol
|
1985
|
0.97
|
|
23
|
Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.
|
J Acquir Immune Defic Syndr
|
2001
|
0.96
|
|
24
|
Despite high concordance, distinct mutational and phenotypic drug resistance profiles in human immunodeficiency virus type 1 RNA are observed in gastrointestinal mucosal biopsy specimens and peripheral blood mononuclear cells compared with plasma.
|
J Infect Dis
|
2000
|
0.92
|
|
25
|
Resistance profiles in patients with viral rebound on potent antiretroviral therapy.
|
J Infect Dis
|
2000
|
0.92
|
|
26
|
Resistance to antiretroviral therapy among patients in Uganda.
|
J Acquir Immune Defic Syndr
|
2001
|
0.91
|
|
27
|
Maternal perception of fetal motor activity.
|
Br Med J
|
1979
|
0.90
|
|
28
|
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapy.
|
J Infect Dis
|
2000
|
0.88
|
|
29
|
Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
|
Hepatology
|
1999
|
0.85
|
|
30
|
The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.
|
J Neurol Neurosurg Psychiatry
|
1983
|
0.85
|
|
31
|
Myocardial ischaemia after withdrawal of salbutamol for pre-term labour.
|
Lancet
|
1979
|
0.84
|
|
32
|
Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure.
|
AIDS Res Hum Retroviruses
|
2001
|
0.84
|
|
33
|
Distribution of K103N and/or Y181C HIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors.
|
J Antimicrob Chemother
|
2001
|
0.82
|
|
34
|
Performance of drug resistance assays in testing HIV-1 non-B subtypes.
|
Clin Microbiol Infect
|
2003
|
0.82
|
|
35
|
Sinusoidal rhythm caused by fetal hemorrhage during fetoscopy.
|
J Perinat Med
|
1984
|
0.81
|
|
36
|
Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy.
|
AIDS Res Hum Retroviruses
|
2001
|
0.80
|
|
37
|
R211K and L214F do not invariably confer high level phenotypic resistance to thymidine analogs in zidovudine-naive patients with M184V.
|
J Acquir Immune Defic Syndr
|
2001
|
0.80
|
|
38
|
Acute congestive cardiac failure in a hypertensive woman receiving salbutamol for premature labour.
|
Br Med J
|
1980
|
0.80
|
|
39
|
Hepatitis delta virus attaches to human hepatocytes via human liver endonexin II, a specific HBsAg binding protein.
|
J Viral Hepat
|
1994
|
0.78
|
|
40
|
Host and tissue tropism of hepatitis B virus.
|
Liver
|
1992
|
0.78
|
|
41
|
Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene.
|
AIDS Res Hum Retroviruses
|
2001
|
0.77
|
|
42
|
Failure of a ritonavir plus saquinavir-based rescue regimen precludes the use of protease inhibitors.
|
AIDS
|
2000
|
0.76
|
|
43
|
Influence of the administration of human annexin V on in vitro binding of small hepatitis B surface antigen to human and to rat hepatocytes and on in vitro hepatitis B virus infection.
|
J Viral Hepat
|
2000
|
0.76
|
|
44
|
Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study.
|
AIDS
|
2001
|
0.76
|
|
45
|
Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimens.
|
Sex Transm Infect
|
2001
|
0.75
|
|
46
|
Hepatitis B virus: specific binding and internalization of small HBsAg by human hepatocytes.
|
J Gen Virol
|
1995
|
0.75
|
|
47
|
The safety of fetoscopy: (I). Effect of umbilical vessel puncture on the fetal heart rate and cord histology.
|
Prenat Diagn
|
1983
|
0.75
|
|
48
|
RT-PCR for Amplification of Specific Fragments of HIV-1 Genome.
|
Methods Mol Med
|
2000
|
0.75
|
|
49
|
Mechanism of urinary continence after colposuspension: barrier studies.
|
Br J Obstet Gynaecol
|
1985
|
0.75
|
|
50
|
Low prevalence of antiretroviral drug resistance among HIV-1 seroconverters in London, 1984-1991.
|
J Infect
|
2002
|
0.75
|
|
51
|
Supraventricular tachycardia in utero with two-to-one block in fetal monitor.
|
Lancet
|
1981
|
0.75
|